Zobrazeno 1 - 10
of 2 232
pro vyhledávání: '"Gubareva LV"'
Autor:
Gao R, Pascua PNQ, Chesnokov A, Nguyen HT, Uyeki TM, Mishin VP, Zanders N, Cui D, Jang Y, Jones J, La Cruz J, Di H, Davis CT, Gubareva LV
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 Nov; Vol. 30 (11), pp. 2303-2312. Date of Electronic Publication: 2024 Oct 08.
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2024 Jul; Vol. 30 (7), pp. 1410-1415.
Autor:
Chesnokov A; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Ivashchenko AA; ChemDiv, San Diego, California, USA., Matsuzaki Y; Department of Infectious Diseases, Yamagata University Faculty of Medicine, Yamagata, Japan., Takashita E; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Tokyo, Japan., Mishin VP; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA., Ivachtchenko AV; ChemDiv, San Diego, California, USA.; AVISA LLC, Hallandale Beach, Florida, USA., Gubareva LV; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0172723. Date of Electronic Publication: 2024 Apr 08.
New insights into the neuraminidase-mediated hemagglutination activity of influenza A(H3N2) viruses.
Autor:
Gao R; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Pascua PNQ; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Nguyen HT; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Chesnokov A; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Champion C; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA; Chippewa Government Solutions, Sault Sainte Marie, MI, USA., Mishin VP; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Wentworth DE; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Gubareva LV; Influenza Division, NCIRD, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Electronic address: lgubareva@cdc.gov.
Publikováno v:
Antiviral research [Antiviral Res] 2023 Oct; Vol. 218, pp. 105719. Date of Electronic Publication: 2023 Sep 15.
Autor:
Nguyen HT; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Chesnokov A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., De La Cruz J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Pascua PNQ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Mishin VP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Jang Y; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Jones J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Di H; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Ivashchenko AA; ChemDiv, 12760 High Bluff Drive, Ste. 370, San Diego, CA 92130, USA., Killian ML; National Veterinary Services Laboratories, U.S. Department of Agriculture (USDA), Ames, IA 50010, USA., Torchetti MK; National Veterinary Services Laboratories, U.S. Department of Agriculture (USDA), Ames, IA 50010, USA., Lantz K; National Veterinary Services Laboratories, U.S. Department of Agriculture (USDA), Ames, IA 50010, USA., Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Davis CT; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA., Ivachtchenko AV; ChemDiv, 12760 High Bluff Drive, Ste. 370, San Diego, CA 92130, USA; AVISA LLC, 1835 E. Hallandale Beach Blvd, #442, Hallandale Beach, FL 33009, USA., Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA. Electronic address: lgubareva@cdc.gov.
Publikováno v:
Antiviral research [Antiviral Res] 2023 Sep; Vol. 217, pp. 105679. Date of Electronic Publication: 2023 Jul 24.
Autor:
Patel MC; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Flanigan D; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; General Dynamics Information Technology, Atlanta, GA, USA., Feng C; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA., Chesnokov A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Nguyen HT; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Elal AA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; Cherokee Nation Integrated Health, L.L.C., Atlanta, GA, USA., Steel J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kondor RJ; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lgubareva@cdc.gov., Mishin VP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publikováno v:
Antiviral research [Antiviral Res] 2022 Dec; Vol. 208, pp. 105457. Date of Electronic Publication: 2022 Nov 01.
Autor:
Govorkova EA; WHO Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds, St. Jude Children's Research Hospital, Memphis, TN, 38105-3678, USA. Electronic address: elena.govorkova@stjude.org., Takashita E; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo, 208-0011, Japan., Daniels RS; WHO Collaborating Centre for Reference and Research on Influenza, The Francis Crick Institute, Worldwide Influenza Centre, 1 Midland Road, London, NW1 1AT, United Kingdom., Fujisaki S; WHO Collaborating Centre for Reference and Research on Influenza, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo, 208-0011, Japan., Presser LD; National Institute for Public Health and the Environment, PO Box 1, 3720, BA, Bilthoven, the Netherlands., Patel MC; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centres for Disease Control and Prevention, 1600 Clifton RD NE, MS H17-5, Atlanta, GA, 30329, USA., Huang W; WHO Collaborating Centre for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China., Lackenby A; National Infection Service, Public Health England, London, NW9 5HT, United Kingdom., Nguyen HT; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centres for Disease Control and Prevention, 1600 Clifton RD NE, MS H17-5, Atlanta, GA, 30329, USA., Pereyaslov D; Global Influenza Programme, World Health Organization, Avenue Appia 20, 1211, Geneva, 27, Switzerland., Rattigan A; WHO Collaborating Centre for Reference and Research on Influenza, The Francis Crick Institute, Worldwide Influenza Centre, 1 Midland Road, London, NW1 1AT, United Kingdom., Brown SK; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Samaan M; Global Influenza Programme, World Health Organization, Avenue Appia 20, 1211, Geneva, 27, Switzerland., Subbarao K; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia., Wong S; Public Health Laboratory Centre, 382 Nam Cheong Street, Hong Kong, China., Wang D; WHO Collaborating Centre for Reference and Research on Influenza, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China., Webby RJ; WHO Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds, St. Jude Children's Research Hospital, Memphis, TN, 38105-3678, USA., Yen HL; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Zhang W; Global Influenza Programme, World Health Organization, Avenue Appia 20, 1211, Geneva, 27, Switzerland., Meijer A; National Institute for Public Health and the Environment, PO Box 1, 3720, BA, Bilthoven, the Netherlands., Gubareva LV; WHO Collaborating Centre for Surveillance, Epidemiology and Control of Influenza, Centres for Disease Control and Prevention, 1600 Clifton RD NE, MS H17-5, Atlanta, GA, 30329, USA.
Publikováno v:
Antiviral research [Antiviral Res] 2022 Apr; Vol. 200, pp. 105281. Date of Electronic Publication: 2022 Mar 12.
Autor:
Ison MG; Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Electronic address: mgison@northwestern.edu., Hayden FG; Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, VA, USA. Electronic address: fgh@virginia.edu., Hay AJ; The Francis Crick Institute, London, UK. Electronic address: Alan.Hay@crick.ac.uk., Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: LGubareva@cdc.gov., Govorkova EA; Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address: Elena.Govorkova@stjude.org., Takashita E; National Institute of Infectious Diseases, Tokyo, Japan. Electronic address: emitaka@nih.go.jp., McKimm-Breschkin JL; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Victoria, Australia. Electronic address: jmbvirology@gmail.com.
Publikováno v:
Antiviral research [Antiviral Res] 2021 Oct; Vol. 194, pp. 105158. Date of Electronic Publication: 2021 Aug 04.
Autor:
Mohan T, Nguyen HT, Kniss K, Mishin VP, Merced-Morales AA, Laplante J, St George K, Blevins P, Chesnokov A, De La Cruz JA, Kondor R, Wentworth DE, Gubareva LV
Publikováno v:
Emerging infectious diseases [Emerg Infect Dis] 2021 Jul; Vol. 27 (7), pp. 1953-1957.
Autor:
Patel MC; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Chesnokov A; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Jones J; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mishin VP; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., De La Cruz JA; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Nguyen HT; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; General Dynamics Information Technology, Atlanta, GA, USA., Zanders N; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA; General Dynamics Information Technology, Atlanta, GA, USA., Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Davis TC; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Gubareva LV; Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: lgubareva@cdc.gov.
Publikováno v:
Antiviral research [Antiviral Res] 2021 Apr; Vol. 188, pp. 105035. Date of Electronic Publication: 2021 Feb 10.